Heidelberg Pharma AG (ETR:HPHA)

PRESS RELEASE

published on 03/07/2026 at 02:03, 7 months 30 days ago

EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Heidelberg Pharma AG announces amendment to royalty agreement with HealthCare Royalty and partnership with Soleus Capital, securing upfront and milestone payments

FDA Approval HealthCare Royalty Heidelberg Pharma AG Royalty Agreement Soleus Capital
BRIEF

published on 01/29/2026 at 13:32, 9 months 8 days ago

Heidelberg Pharma obtient un paiement d'étape de Takeda

Développement Clinique Heidelberg Pharma Paiement D'étape Partenariat Takeda Technologie ATAC
BRIEF

published on 01/29/2026 at 13:32, 9 months 8 days ago

Heidelberg Pharma Attains Milestone Payment from Takeda

Clinical Development Heidelberg Pharma Milestone Payment ATAC Technology Takeda Partnership
PRESS RELEASE

published on 01/29/2026 at 13:27, 9 months 8 days ago

Heidelberg Pharma Received Development Milestone Payment from Partner Takeda
Heidelberg Pharma AG receives development milestone payment from partner Takeda for progress in ADC technology clinical trial

Takeda Clinical Trial Heidelberg Pharma ADC Technology Development Milestone
BRIEF

published on 12/17/2025 at 09:26, 10 months 20 days ago

Heidelberg Pharma confrontée à des difficultés financières dans un contexte d'ajustements stratégiques

Essais Cliniques Réduction Des Coûts Heidelberg Pharma Défis Financiers Recherche Sur Le Cancer
BRIEF

published on 12/17/2025 at 09:26, 10 months 20 days ago

Heidelberg Pharma Faces Financial Hurdles Amid Strategic Adjustments

Clinical Trials Cancer Research Cost-cutting Heidelberg Pharma Financial Challenges
PRESS RELEASE

published on 12/17/2025 at 09:21, 10 months 20 days ago

Heidelberg Pharma: Letter from the CEO
Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively

CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
BRIEF

published on 11/24/2025 at 18:03, 11 months 11 days ago

Heidelberg Pharma nomme le Dr Liu au poste de PDG dans un contexte de changements au sein de sa direction.

Heidelberg Pharma Industrie Biotechnologique CAN Changement Exécutif Dr Jeffery Liu
BRIEF

published on 11/24/2025 at 18:03, 11 months 11 days ago

Heidelberg Pharma Appoints Dr. Liu as CEO Amid Management Changes

Biotech Industry Heidelberg Pharma ADCs Executive Change Dr. Jeffery Liu
PRESS RELEASE

published on 11/24/2025 at 17:58, 11 months 11 days ago

Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma appoints Dr. Dongzhou Jeffery Liu as Chairman and CEO, replacing Prof. Andreas Pahl. The biotech company focuses on ADC technology for cancer treatment

Cancer Treatment Heidelberg Pharma ADC Technology Executive Management Board Dongzhou Jeffery Liu

Published on 11/06/2026 at 13:00, 2 hours 6 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 hours 36 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 hours 36 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 5 hours 6 minutes ago

Mongolia Tax Audit
Published on 11/06/2026 at 05:15, 9 hours 51 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins

View all ACCESSWIRE

Published on 11/06/2026 at 14:50, 16 minutes ago

New UN guide keeps people in charge of AI in smart cities
Published on 11/06/2026 at 14:45, 21 minutes ago

Ningbo Consensus on Collaborative Development released at 2026 Global Mayors Dialogue · Ningbo
Published on 11/06/2026 at 14:40, 26 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/06/2026 at 14:40, 26 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/06/2026 at 14:39, 27 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

View all EQS

Published on 11/06/2026 at 11:05, 4 hours 1 minute ago

voting rights
Published on 11/06/2026 at 11:05, 4 hours 1 minute ago

droits de vote
Published on 11/06/2026 at 09:07, 5 hours 59 minutes ago

Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 6 hours 2 minutes ago

Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 20 hours 45 minutes ago

Capital et droits de vote au 31 octobre 2026

View all LES ECHOS COMFI WIRE

News